Funds should start flowing at the start of 2007 in the €50 billion Framework Programme 7 after the European Parliament approved the budget.

Novartis’s move to take over UK biotech NeuTec Pharma at a large premium highlights how the so-called “superbugs” have reinvigorated pharma’s interest in antibiotics.

York University's Centre for Novel Agricultural Products has won a grant from the Bill & Melinda Gates Foundation to complete research into an antimalarial plant.

It may not be possible to write a rulebook on how to innovate, but there is no harm in reading attempts to do so.

The University of Manchester is launching a £10 million research centre for developing sustainable energy technologies.

Wine and biotechnology come together in yet another genome project.

European Union has voted to continue funding embryonic stem cell research after a heated debate at the European Parliament on Tuesday.

IBM offers a few details of its new consultancy service for R&D management. Pity about the jargon.

A team of researchers from ETH-Zürich is looking for investment for their spin-off company, XpresSys, to commercialise novel protein expression technology. The technology has the potential to revolutionise screening process for new drugs.

The international treaty on plant genetic resources needs a gesture of trust to repair the atmosphere of suspicion that has developed, argues Emile Frison from the International Plant Genetic Resources Institute.